Tag: Olaparib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Olaparib

PARP rivals close in on AZ and Merck's market leading Lynparza - - Pharmaphorum

Added to Collection on: 2022-10-04 18:29:25

Tags for this article:

Organic compounds
Chemical compounds
Cancer
Lactams
PARP inhibitors
Prostate cancer
Rucaparib
Enzalutamide
Olaparib
Abiraterone acetate
MCRPC
Chemotherapy
Pfizer
Clovis Oncology

Click the tags to see associated articles and topics

View Article Details
Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo

Added to Collection on: 2022-11-18 20:19:28

Tags for this article:

Clinical medicine
Medicine
Monoclonal antibodies
Cancer treatments
Organic compounds
Durvalumab
Lung cancer
AstraZeneca
PD-1 and PD-L1 inhibitors
PARP inhibitor
Non-small-cell lung carcinoma
Olaparib
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug ... - Yahoo Finance

Added to Collection on: 2022-12-15 13:24:03

Tags for this article:

Drugs
RTT
Chemical compounds
Hormones
Glucocorticoids
Mineralocorticoids
Prostate cancer
PARP inhibitors
Olaparib
Merck & Co.
MCRPC
Prednisone

Click the tags to see associated articles and topics

View Article Details
AstraZeneca and Merck Provide - GuruFocus.com

Added to Collection on: 2022-12-15 12:00:36

Tags for this article:

Medicine
Clinical medicine
Cancer
Cancer treatments
RTT
Lactams
Prostate cancer
Oncology
Adjuvant therapy
Chemotherapy
Bevacizumab
Olaparib
abiraterone
Enzalutamide
United States
Canada
AstraZeneca
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
PARP Inhibitor Market Future Business Opportunities 2022-2028 - Digital Journal

Added to Collection on: 2022-12-25 16:37:35

Tags for this article:

Organic compounds
Chemical compounds
Business
Lactams
PARP inhibitors
Market structure
Programmed cell death
DNA repair
Poly (ADP-ribose) polymerase
Olaparib
Market research
Rucaparib

Click the tags to see associated articles and topics

View Article Details
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ... - Investing News Network

Added to Collection on: 2022-12-29 23:50:31

Tags for this article:

Medicine
Clinical medicine
Cancer
Cancer treatments
RTT
Oncology
Lactams
PARP inhibitors
Adjuvant therapy
Olaparib
Chemotherapy
Prostate cancer
abiraterone
United States

Click the tags to see associated articles and topics

View Article Details
Adding Durvalumab and Olaparib to Chemo Improves PFS in Endometrial Cancer

Added to Collection on: 2023-10-21 21:32:19

Tags for this article:

Orphan drugs
Breakthrough therapy
Monoclonal antibodies
Antineoplastic drugs
Durvalumab
Lactams
Olaparib
PARP inhibitor
Progression-free survival
Carboplatin
Paclitaxel

Click the tags to see associated articles and topics

View Article Details
Olaparib by AstraZeneca for Diffuse Large B-Cell Lymphoma: Likelihood of Approval

Added to Collection on: 2023-10-27 23:15:17

Tags for this article:

Orphan drugs
PARP inhibitors
Gynaecological cancer
Infectious causes of cancer
Breakthrough therapy
Olaparib
Bevacizumab
Ovarian cancer
Cancer
Breast cancer
Triple-negative breast cancer
Non-small-cell lung cancer

Click the tags to see associated articles and topics

View Article Details
Boston Biotech Could Have Blockbuster Sales Research Report

Added to Collection on: 2024-01-03 19:18:48

Tags for this article:

Exelixis
Investment banking
Olaparib
Protein arginine methyltransferase 5
Robert Burns
Tango Therapeutics Inc.
Raghuram Selvaraju

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi shows benefits in endometrial cancer trial

Added to Collection on: 2024-03-19 17:32:10

Tags for this article:

Orphan drugs
Cancer immunotherapy
Antineoplastic drugs
Monoclonal antibodies
Durvalumab
Checkpoint inhibitor
Endometrial cancer
Olaparib
Clinical endpoint
AstraZeneca

Click the tags to see associated articles and topics

View Article Details